Genistein causes regression of endometriotic implants in the rat model

Fertility and Sterility

Volumn 88, Issue 4 SUPPL., 2007, Pages 1129-1134

  Yavuz, Emrah ^a   Oktem, Mesut ^a   Esinler, Ibrahim ^a   Toru, Serap Arat ^a   Zeyneloglu, Hulusi B ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Endometriosis; genistein; raloxifene; rat model; SERM

Indexed keywords

GENISTEIN; RALOXIFENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HISTOLOGY; HISTOPATHOLOGY; IMPLANT; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENISTEIN; PERITONEAL CAVITY; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 34848855362     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.01.010     Document Type: Article

References (25)

1. Kennedy S., Bergqvist A., Chapron C., D'Hooghe T., Dunselman G., Greb R., et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20 (2005) 2698-2704
2. Amsterdam L.L., Gentry W., Jobanputra S., Wolf M., Rubin S.D., and Bulun S.E. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 84 (2005) 300-304
3. Vignali M., Infantino M., Matrone R., Chiodo I., Somigliana E., Busacca M., et al. Endometriosis: novel etiopathogenetic concepts and clinical perspectives. Fertil Steril 78 (2002) 665-678
4. Khovidhunkit W., and Shoback D.M. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med 130 (1999) 431-439
5. Dhingra K. Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer. Cancer Invest 19 (2001) 649-659
6. Deroo B.J., and Korach K.S. Estrogen receptors and human disease. J Clin Invest 116 (2006) 561-570
7. Ferrero S., Abbamonte L.H., Anserini P., Remorgida V., and Ragni N. Future perspectives in the medical treatment of endometriosis. Obstet Gynecol Surv 60 (2005) 817-826
8. Swisher D., Tague R.M., and Seyler D.E. Effect of the selective estrogen receptor modulator raloxifene on explanted uterine growth in rats. Drug Dev Res 36 (1995) 43-45
9. Fanning P., Kuehl T., Lee R., Pearson S., Wincek T., Pliego J., et al. Video mapping to assess efficacy of an antiestrogen (raloxifene) on spontaneous endometriosis in the rhesus monkey, Macaca mulatta. In: Kuehl T.J. (Ed). Bunkley Day proceedings (1996), Texas A&M University Health Science Center, Temple, TX 51-61
10. Yao Z., Shen X., Capodanno I., Donnelly M., Fenyk-Melody J., Hausamann J., et al. Validation of rat endometriosis model by using raloxifene as a positive control for the evaluation of novel SERM compounds. J Invest Surg 18 (2005) 177-183
11. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262 (1987) 5592-5595
12. Markovits J., Linassier C., Fosse P., Couprie J., Pierre J., Jacquemin-Sablon A., et al. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res 49 (1989) 5111-5117
13. Kogiso M., Sakai T., Mitsuya K., Komatsu T., and Yamamoto S. Genistein suppresses antigen-specific immune responses through competition with 17β-estradiol for estrogen receptors in ovalbumin-immunized BALB/c mice. Nutrition 22 (2006) 802-809
14. Kayisli U.A., Aksu C.A., Berkkanoglu M., and Arici A. Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab 87 (2002) 5539-5544
15. Cotroneo M.S., and Lamartiniere C.A. Pharmacologic, but not dietary, genistein supports endometriosis in a rat model. Toxicol Sci 61 (2001) 68-75
16. Rajkumar K., Schott P.W., and Simpson C.W. The rat as an animal model for endometriosis to examine recurrence of ectopic endometrial tissue after regression. Fertil Steril 53 (1990) 921-925
17. Keenan J.A., Williams-Boyce P.K., Massey P.J., Chen T.T., Caudle M.R., and Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril 72 (1999) 135-141
18. Grow D.R., and Reece M.T. The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception. Hum Reprod 15 Suppl 3 (2000) 30-38
19. Baker V.L., Draper M., Paul S., Allerheiligen S., Glant M., Shifren J., et al. Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles. J Clin Endocrinol Metab 83 (1998) 6-13
20. Kurzer M.S., and Xu X. Dietary phytoestrogens. Annu Rev Nutr 17 (1997) 353-381
21. Staar S., Richter D.U., Makovitzky J., Briese V., and Bergemann C. Stimulation of endometrial glandular cells with genistein and daidzein and their effects on ERα- and ERβ-mRNA and protein expression. Anticancer Res 25 (2005) 1713-1718
22. Foth D., and Cline J. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 68 Suppl (1998) 1413S-1417S
23. Lu L.J., Anderson K.E., Grady J.J., and Nagamani M. Effects of an isoflavone-free soy diet on ovarian hormones in premenopausal women. J Clin Endocrinol Metab 86 (2001) 3045-3052
24. Le Bail J.C., Champavier Y., Chulia A.J., and Habrioux G. Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci 66 (2000) 1281-1291
25. Ibrahim A.R., and Abul-Hajj Y.J. Aromatase inhibition by flavonoids. J Steroid Biochem Mol Biol 37 (1990) 257-260